Company / Operating Income per Share
Monte Rosa Therapeutics, Inc. Operating Income per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$1.10
FY2024
5-year range
-$18.47 / -$1.10
FY2020-FY2024
Trend
+60.6%
vs FY2023
Sector context
#89 of 201
Health Care
What the data says
At $-1.10, Monte Rosa Therapeutics, Inc.'s operating income per share ranks #89 of 201 in the Health Care sector. Improved from $-2.38 to $-1.10 over the past 2 years.
Based on SEC 10-K filings.
-1.10 in FY2024.
Improved from $-2.38 to $-1.10 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#89 of 201 in Health CareTop 44% of 201This company -$1.10 Sector average -$28.56
▼
+96.2% above sector average
Key checks
Key Insights
- In FY2024, operating income per share increased 60.6% year-over-year.
- Ranks #89 out of 201 companies in the Health Care sector.
- Lowest operating income per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$1.10 | +60.6% |
| FY2023 | -$2.79 | -17.2% |
| FY2022 | -$2.38 | +18.4% |
| FY2021 | -$2.92 | +84.2% |
| FY2020 | -$18.47 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026